Content is intended for people aged >18 years only
Actual patient. Results may vary.
We create products and technologies that drive the advancement of aesthetic medicine.
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes filler treatments, body contouring, plastics, skin care, and more.
With our own research and development function focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
We are driven to help consumers make informed decisions about their aesthetic needs.
It's our job to stand out.
The aesthetics market is changing fast. We know change never stops, and we‘re constantly seeking to better understand the mindsets and motivations of the consumers we serve in order to focus on meeting unmet needs as we innovate.
Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
Actual patient. Results may vary.
Adverse events should be reported. UK reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.
Irish healthcare professionals (HCPs) are asked to report any suspected adverse reactions via HPRA Pharmacovigilance; website https://www.hpra.ie. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
UK-AGNA-230228 Date of Preparation:- June 2024